Roche Hldg Ltd Spons: (OTC: RHHBY)
$63.20
-0.30 (-0.47%)
Volume 172,984
May 14 03:59 PM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 63.00 - 63.69 |
| 52wk Low - High | 38.61 - 63.81 |
| Previous Close | 63.50 |
| Avg. Volume | 448,465 |
| Industry | LARGE CAP PHARMA |
| Market Cap | 219.09 B |
| Div - Yield | 1.62 - 2.56 |
| Beta | 0.67 |
| PE (Forward) | 15.98 |
| Current Year Est. | 3.97 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
 3 |
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
118 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 15.98 |
| PEG Ratio | 2.08 |
| Current Year Est. | 3.97 |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 05-10-2013 |
| EPS Last Year | NA |
| Expected Earnings Growth | 7.69% |
Company Description
Roche Holding AG is a research-based, product-focused organization dedicated to the discovery and early clinical development of pharmaceuticals and drugs, fine chemicals and vitamins, fragrances and flavors, diagnostic equipment and liquid crystals. The Company distributes its products throughout Europe, the United States, Asia and Latin America.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (03/2013) |
Next Qtr (06/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | 3.97 | 4.27 |
| Number of Estimates | 0 | 0 | 3 | 3 |
| Low Estimate | NA | NA | 3.91 | 4.18 |
| High Estimate | NA | NA | 4.04 | NA |
| Year Ago EPS | NA | NA | 3.69 | 3.97 |
| EPS Growth | NA | NA | 7.68% | 7.47% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| ROCHE HLDG LTD | RHHBY | 63.50 | |
|
| ABBOTT LABS | ABT | 36.35 | |
|
| ABBVIE INC | ABBV | 44.54 | |
|
| ALLERGAN INC | AGN | 103.86 | |
|
| ASTRAZENECA PLC | AZN | 51.36 | |
|
| BAYER A G -ADR | BAYRY | 108.44 | |
|
| BRISTOL-MYERS | BMY | 40.94 | |
|
| GLAXOSMITHKLINE | GSK | 51.67 | |
|
| JOHNSON & JOHNS | JNJ | 85.85 | |
|
| LILLY ELI & CO | LLY | 56.28 | |
|
Sector:Medical>> Industry:LARGE CAP PHARMA
COMPARE TICKER vs. Its Peers
Zacks Commentary
Lilly Scraps Oncology Candidate
May 13, 2013
PDL BioPharma Misses Earnings Ests
May 13, 2013
Narrower-than-Expected Loss at Seattle Genetics
May 08, 2013
Narrower-Than-Expected Loss at Incyte
May 03, 2013
Positive News for Roche
Apr 29, 2013
ImmunoGen Narrows Loss
Apr 29, 2013
PDL BioPharma to Finance Avinger
Apr 23, 2013
Pivotal Progresses with Vascazen
Apr 16, 2013
Financials
| EPS TTM | NA |
| Sales | 49,208 |
| Net Income | NA |
| Price/Earnings | NA |
| Price/Book | 12.27 |
| Price/Cash Flow | 14.44 |
| Price/Sales | NA |
News
Benzinga`s M&A Chatter for Friday May 10, 2013 - Benzinga
May 11, 2013
Tackling Cancer: Endometrial Cancer`s Biggest Current & Upcoming Players - TheMotleyFool
May 11, 2013
Tackling Cancer: Endometrial Cancer`s Biggest Current and Upcoming Players - TheMotleyFool
May 11, 2013
Possible Bullish Inside Day Candle Pattern Detected for Roche Holding (NASDAQ:RHHBY) - Financial News Network Online - News Corner
May 3, 2013
Regeneron Profit Skyrockets As Eylea Goes Blockbuster - Investors Business Daily
May 3, 2013
Regeneron Stock Soars On Q1 Results, Guidance Hike - Investors Business Daily
May 3, 2013
Why Allergan`s Pain Is Regeneron`s Gain - TheMotleyFool
May 1, 2013
Apple Sells $17 Billion In Bonds In Historic Offering - Investors Business Daily
Apr 30, 2013
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 4 |
| Average Target Price | 58.90 |
| Industry Rank by ABR | 118 out of 265 |
| Rank in Industry | 1 out of 15 |
